BSL

Basilea Pharmace Stock

StockStock
ISIN: CH0011432447
Ticker: BSLN
CH0011432447
BSLN

Price

Historical dividends and forecast

All dividend data

 


$5.363

CHART BY

Frequently asked questions

What is Basilea Pharmace's market capitalization?

The market capitalization of Basilea Pharmace is $624.33M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Basilea Pharmace?

Basilea Pharmace's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.319. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Basilea Pharmace's stock?

Currently, 6 analysts cover Basilea Pharmace's stock, with a consensus target price of $75.70. Analyst ratings provide insights into the stock's expected performance.

What is Basilea Pharmace's revenue over the trailing twelve months?

Over the trailing twelve months, Basilea Pharmace reported a revenue of $169.01M.

What is the EBITDA for Basilea Pharmace?

Basilea Pharmace's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$7.53M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Basilea Pharmace?

Basilea Pharmace has a free cash flow of $10.36M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Basilea Pharmace's stock?

The 5-year beta for Basilea Pharmace is 1.07. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Basilea Pharmace have, and what sector and industry does it belong to?

Basilea Pharmace employs approximately 156 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Basilea Pharmace's shares?

The free float of Basilea Pharmace is 12.11M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$624.33M

5Y beta

 
1.07

EPS (TTM)

 
-$0.319

Free Float

 
12.11M

Revenue (TTM)

 
$169.01M

EBITDA (TTM)

 
-$7.53M

Free Cashflow (TTM)

 
$10.36M

Pricing

1D span
$46.55$47.39

Analyst Ratings

The price target is $75.70 and the stock is covered by 6 analysts.

Buy

5

Hold

1

Sell

0

Information

Basilea Pharmaceutica AG Allschwil, formerly known as Basilea Pharmaceutica AG, is a Switzerland-based commercial-stage biopharmaceutical company. The Company operates in one segment, which is the discovery, development, and commercialization of pharmaceutical products to meet the needs of patients with severe bacterial and fungal infections. It launched two hospital brands, Cresemba, which is an intravenous and oral drug for the treatment of invasive fungal infections, and Zevtera, which is an intravenous antibiotic for the treatment of severe bacterial infections, especially pneumonia. Additionally, the Company has several preclinical anti-infective assets in their portfolio. Company's products are present in United States, Canada, Europe, Asia, and Africa.

156

Biotechnology & Drugs

Health Care

Identifier

ISIN

CH0011432447

Primary Ticker

BSLN

Knockouts

Join the conversation